Variable Immobilization Protocol for Arthroplasty of the Carpometacarpal Joint of the Thumb
Launched by UNIVERSITY OF CHICAGO · Mar 30, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the best way to keep the thumb still after surgery for thumb osteoarthritis, a condition that can cause pain and stiffness, especially in middle-aged and older women. The researchers want to find out if keeping the thumb in a cast or splint for different lengths of time after surgery helps people recover better and faster. Participants in the trial will either wear a splint for 2 weeks or a splint that changes to a cast for a total of 6 weeks. By comparing these two groups, the study aims to help doctors create a more effective recovery plan for patients after thumb surgery.
To join the study, participants need to be at least 40 years old and planning to have specific thumb surgeries, such as trapeziectomy. However, those who have had previous thumb surgeries or have certain other medical conditions won’t be eligible. Throughout the study, participants will provide feedback about their recovery and be monitored to see how well they are doing. This information could lead to better treatment options for future patients with similar thumb issues.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age \>= 40 years old
- * Patients undergoing arthroplasty of the first CMC joint including:
- • 1. Trapeziectomy with LRTI
- • 2. Simple Trapeziectomy
- • 3. Suspensionplasty (suture vs. APL)
- Exclusion Criteria:
- • Patients \< 40 years of age
- • Patients who have undergone prior surgical procedures on the thumb base
- • Patients with history of prior procedure at the base of thumb, or those with plan for concomitant carpal tunnel release or thumb metacarpophalangeal (MCP) arthrodesis, will be excluded. Concomitant carpal tunnel surgery may skew outcome surveys, and an arthrodesis procedure will warrant a longer length of immobilization following procedure.
- • Those undergoing implant arthroplasty
- • Patients with a diagnosis of inflammatory arthritis
- • Patients with diagnosis of hypermobility syndrome
About University Of Chicago
The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Patients applied
Trial Officials
Jennifer Wolf, MD
Principal Investigator
University of Chicago
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials